Clincosm LogoSign in Get a demo

Clinical Utility of Neuromodulation on Tinnitus

Sponsor
Hearing and Language Healthcare Center, China Medical University Hsinchu Hospital, Taiwan (Other)
Overall Status
Completed
CT.gov ID
NCT05674435
Collaborator
(none)
26
Enrollment
1
Location
8.9
Actual Duration (Months)
2.9
Patients Per Site Per Month

Study Details

Study Description

Brief Summary

The aim of the present narrative review is to one of the first to critically evaluate the clinical effectiveness of neuromodulation as a therapeutic option for patients with tinnitus. Our method involves conducting a systemic review and the findings reported following PRISMA statement. Pubmed, Cochrane database and Google Scholar databases literature search was conducted for articles reporting the use of neuromodulatory interventions on tinnitus patients. Each article was evaluated using the Cochrane risk of bias tool.

Condition or Disease Intervention/Treatment Phase

    Study Design

    Study Type:
    Observational
    Actual Enrollment :
    26 participants
    Observational Model:
    Other
    Time Perspective:
    Other
    Official Title:
    Clinical Utility of Neuromodulation on Tinnitus: A Systematic Review
    Actual Study Start Date :
    Jan 1, 2022
    Actual Primary Completion Date :
    Jun 30, 2022
    Actual Study Completion Date :
    Sep 30, 2022

    Outcome Measures

    Primary Outcome Measures

    1. Tinnitus severity scores [9 months]

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years to 65 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:

    • Tinnitus patients

    • At least one of the neurofeedback methods

    • Single and multi-center

    • Randomized control trials and observational studies

    Exclusion Criteria:

    • Non-peer-reviewed papers, letters, editorials

    • Not English language

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Hearing and Language Healthcare Center, China Medical University Hsinchu Hospital, Taiwan Hsinchu Taiwan

    Sponsors and Collaborators

    • Hearing and Language Healthcare Center, China Medical University Hsinchu Hospital, Taiwan

    Investigators

    None specified.

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Hearing and Language Healthcare Center, China Medical University Hsinchu Hospital, Taiwan
    ClinicalTrials.gov Identifier:
    NCT05674435
    Other Study ID Numbers:
    • IJS-D-22-01675
    First Posted:
    Jan 6, 2023
    Last Update Posted:
    Jan 6, 2023
    Last Verified:
    Dec 1, 2022
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Additional relevant MeSH terms:
    Tinnitus

    Study Results

    No Results Posted as of Jan 6, 2023